Skip to main content

When to store?

Discover the wide variety of diseases treatable with stem cells

When to store umbilical cord blood stem cells?

The possibility of using stem cells to treat a wide variety of diseases represents today one of the most important tools made available to humans by medical-scientific research.

By contacting a private biobank such as the Bioscience Institute, it is possible to store the stem cells present in the cord blood for preventive purposes, in the event that the newborn is affected by one of the diseases treatable with these cells, or for allogeneic purposes to let them be used by a compatible family member.

List of diseases treatable with stem cells

The list of diseases treatable with stem cells is constantly updated. In many cases these cells are used in approaches that are now considered standard; to these are added numerous cases in which stem cell-based therapies represent promising experimental treatments.

Diseases currently treated with hematopoietic stem cells include, among others:

  • leukemia
  • myelodysplastic syndromes
  • lymphomas
  • anemias
  • hereditary disorders of the immune system
  • hereditary metabolic diseases
  • solid tumors

Other pathologies for which treatments based on the use of umbilical cord stem cells have been tested

The diseases that have been in clinical trials with cord blood or cord tissue stem cells include:

  • Alzheimer’s disease
  • Parkinson’s disease
  • stroke
  • autism
  • cerebral palsy
  • autoimmune diseases
  • cardiovascular disorders
  • diabetes and associated disorders
  • genetic and metabolic diseases
  • arthrosis
  • ankylosing spondylitis
  • damage to cartilage
  • erectile dysfunction
  • ovarian failure

For a complete list click here

Other pathologies for which treatments based on the use of umbilical cord stem cells have been tested

Umbilical cord blood can be collected at the time of delivery, both from physiological and caesarean deliveries. Families wishing to do so must apply for the Export Authorization (approx. 30 days before the delivery) from the Health Department of the hospital where the child will be born.

The Bioscience Institute deals with the administrative, logistical and health aspects, assisting its customers in the procedures necessary to obtain the Export Authorization and in the collection of the blood sample at the facility where the delivery will take place.

For more information on the procedures to follow, you can refer to this page.

Are you pregnant?

Are you thinking of storing your child's stem cells?

Cord blood is the blood that remains in the umbilical cord after the baby is born and is a valuable source of stem cells.

Until recently it was treated as “waste” and eliminated with hospital waste along with the placenta and the umbilical cord. It is currently used in the treatment of around 100 serious diseases.

Request a free consultation